Dextroamphetamine-Cocaine Behavioral Intervention - 5

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Dextroamphetamine; Drug: placebo; Drug: D-amphetamine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000308

NIDA-09262-5

P50-09262-5

Details and patient eligibility

About

The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in cocaine dependent patients.

Enrollment: 54 patients

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

54 participants in 3 patient groups

1

Experimental group

Description:

15 mg of d-amphetamine for first 8 weeks of study and 30 mg for the second 8 weeks

Treatment:

Drug: Dextroamphetamine

2

Experimental group

Description:

30 mg of d-amphetamine for first 8 weeks of study and 60 mg for the second 8 weeks

Treatment:

Drug: D-amphetamine

3

Experimental group

Description:

placebo

Treatment:

Drug: placebo